Martínez-Laguna, Daniel
Carbonell Abella, Cristina
Bastida, José-Carlos
González, Milagros
Micó-Pérez, Rafael M.
Vargas, Francisco
Díaz Torres, Eva
Canals, Laura
,
Funding for this research was provided by:
This study was sponsored by Amgen S.A.
Article History
Received: 28 March 2024
Accepted: 22 April 2024
First Online: 9 May 2024
Declarations
:
: The study was approved by each ethics committee assigned to each center.
: Written or oral informed consent was obtained from all subjects before participating in this study.
: DML: personal fees from Amgen, Lilly, Rubió, Gedeon Ritcher, Pierre Fabre, Grünenthal, Theramex and Italfarmaco. JCB: personal fees from AstraZeneca, Esteve, Boehringer Ingelheim, Bayer, Abbott, Almirall, Amgen, Chiessi, FAES, Grunenthal, GSK, Lilly, Menarini, MSD, Pfizer, Recordatti, Rovi, Servier; MG: personal fees from Amgen, Stada, Rubió, Grünenthal; RMP: fees from Amgen, UCB, Stada; FV: personal fees from Pfizer, Grünenthal, MSD, Amgen, GSK, Lilly, Bristol-Myers Squibb, Servier, P&G Pharmaceuticals, Novartis, Almirall, Sanofi, Mundipharma; ED and LC: Amgen employees.